Invengenx® – Cardiothoracic

Cardiothoracic Surgery

Invengenx® stands as the pinnacle of innovation in cardiothoracic surgery, offering an exceptional solution for repair and reconstruction procedures. Designed with precision and advanced technology, our tissue patches are the ideal choice for a wide range of applications in this critical field.

At the core of Invengenx®’s superior performance is our proprietary elixP™ fixation methodology, which employs a modified glutaraldehyde formulation to crosslink the tissue. This advanced process results in a highly intact and crosslinked collagen matrix, ensuring that each patch is exceptionally supple, elastic, and biocompatible. Our years of dedicated research and development have culminated in a product that not only meets but exceeds the demands of complex cardiothoracic procedures.

Invengenx® is versatile and reliable, making it the go-to solution for various applications, including:

• Congenital Chest Wall Defects: Our patches provide a robust and adaptable material for repairing and reconstructing congenital defects, ensuring optimal outcomes for patients from a young age.
• Heart Valve Leaflets Repair: With their superior elasticity and biocompatibility, Invengenx® patches are ideal for restoring function and integrity to damaged heart valve leaflets.
• Tetralogy of Fallot: Our patches support the complex repair and reconstruction required in cases of Tetralogy of Fallot, contributing to successful long-term results.

Our commitment extends beyond the product itself; we are dedicated to providing clinicians with a material that is easy to handle and work with, ensuring seamless integration into surgical procedures. For patients, Invengenx® represents a promise of quality and reliability, offering peace of mind in every surgical intervention.

At Tisgenx, Inc., we understand the critical nature of cardiothoracic surgery and are unwavering in our commitment to delivering products that enhance surgical outcomes and improve patient care. Trust in Invengenx® for a future where innovation and quality converge to meet the highest standards of cardiothoracic repair and reconstruction.